cancer weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of cancer weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Endometrial Ablation
Five studies evaluating NovaSure system presented at AAGL meeting
December 14th, 2004
Cytyc Corp. (CYTC) announced that five studies evaluating safety, clinical performance, and ease-of-use for its NovaSure System for endometrial ablation were presented at the 33rd annual meeting of the American Association of Gynecologic Laparoscopists (AAGL) held in San Francisco, Calitornia. The results indicate NovaSure is safe and effective in treating excessive menstrual bleeding in patients with Type I and Type II fibroids, compatible with an office setting, and that Essure hysteroscopic sterilization is achievable following the procedure. A study by Tamas Fulop, MD, of St. Imre Teaching Hospital in Budapest, Hungary, performed a 5-year...
Source: cancer weekly (2004-12-14)
|
